All American adults over the age of 18 should receive COVID-19 booster shots, Centers for Disease Control and Prevention director Rochelle Walensky said. Her recommendation marked a departure from the agency’s previous stance on boosters. (Politico)

A Food and Drug Administration panel is meeting to discuss Merck’s COVID-19 antiviral pill. The panel will vote on whether to recommend authorization of the pill for high-risk patients. (The New York Times)

Immunogen’s antibody drug mirvetuximab soravtansine reduced tumors in 32% of advanced ovarian cancer patients in a late-stage clinical trial. The company hopes to submit the treatment to the Food and Drug Administration for accelerated approval. (STAT)

GlaxoSmithKline has named former Pfizer chief scientific officer Philip Dormitzer as its global head of vaccines R&D. Dormitzer’s addition is part of GSK’s push to delve further into mRNA. (Endpoints News)

Elizabeth Holmes testified Monday that she endured sexual abuse from former Theranos COO Ramesh Balwani. Both Holmes and Balwani face federal fraud charges over misleading doctors, investors and patients about Theranos’ capabilities. (CNN)